MedPath

Gila Therapeutics, Inc.

Gila Therapeutics, Inc. logo
🇺🇸United States
Ownership
Holding
Established
2014-01-01
Employees
1
Market Cap
-
Website
http://www.gilatherapeutics.com

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A Dose Escalating Study to Assess the Safety and Tolerability of GT-001

Phase 1
Completed
Conditions
Feeding and Eating Disorders
Interventions
First Posted Date
2018-04-06
Last Posted Date
2018-04-06
Lead Sponsor
Gila Therapeutics, Inc.
Target Recruit Count
12
Registration Number
NCT03490786
Locations
🇺🇸

Orange County Research Center, Tustin, California, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.